Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | DFTX Definium Therapeutics, Inc. - Common | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $40.25 +3.5% | $16.41 -1.6% |
| StockIQ Score | 52C- Moderate Risk: Medium | 35F Weak Risk: High |
| Technical | 46D+ | 13F |
| Fundamental | 45D+ | 35F |
| Growth | 38F | 50C- |
| Fair Value | 50C- | 38F |
| News | 100A+ | 50C- |
| Quality | 55C | 50C- |
| Risk | 54C- | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Definium Therapeutics (DFTX) scores higher overall with a MODERATE rating, outperforming Ascentage Pharma (AAPG) in investor (46 vs. 37), fundamental (45 vs. 35), and valuation (50 vs. 38) scores. AAPG leads only in growth (50 vs. 38), while DFTX’s technical score (23 vs. 18) is still stronger. AAPG’s WEAK rating reflects its weaker overall performance.